Feedback / Questions
VIS-101 - Aosaikang Pharma, AffaMed Therap
https://www.globenewswire.com/news-release/2026/03/09/3251682/0/en/NovaBridge-and-Visara-Announce-Positive-Results-from-VIS-101-Phase-2a-Wet-AMD-Study.html
Mar 9, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next